Back to News
Market Impact: 0.2
Corteva Consensus Price Target Lowered by 10.07% to $35.13
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The aggregate one-year analyst price target for Corteva was revised down 10.07% to $35.13 per share from $39.06. The prior estimate was dated October 20, 2026; the article provides no explanation for the revision or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
CTVA-0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares